845 related articles for article (PubMed ID: 24768294)
1. Clinical utility of Aspergillus galactomannan and PCR in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies.
Heng SC; Chen SC; Morrissey CO; Thursky K; Manser RL; De Silva HD; Halliday CL; Seymour JF; Nation RL; Kong DC; Slavin MA
Diagn Microbiol Infect Dis; 2014 Jul; 79(3):322-7. PubMed ID: 24768294
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of risk factors for invasive pulmonary aspergillosis and detection of diagnostic values of galactomannan and PCR methods in bronchoalveolar lavage samples from non-neutropenic intensive care unit patients].
Özger S; Hızel K; Kalkancı A; Aydoğdu M; Civil F; Dizbay M; Gürsel G
Mikrobiyol Bul; 2015 Oct; 49(4):565-75. PubMed ID: 26649414
[TBL] [Abstract][Full Text] [Related]
3. Aspergillus galactomannan antigen assay in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis.
Park SY; Lee SO; Choi SH; Sung H; Kim MN; Choi CM; Hong SB; Oh YM; Shim TS; Koh Y; Kim YS; Woo JH; Kim SH
J Infect; 2010 Dec; 61(6):492-8. PubMed ID: 20833201
[TBL] [Abstract][Full Text] [Related]
4. Performance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis.
Hoenigl M; Prattes J; Spiess B; Wagner J; Prueller F; Raggam RB; Posch V; Duettmann W; Hoenigl K; Wölfler A; Koidl C; Buzina W; Reinwald M; Thornton CR; Krause R; Buchheidt D
J Clin Microbiol; 2014 Jun; 52(6):2039-45. PubMed ID: 24671798
[TBL] [Abstract][Full Text] [Related]
5. Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients.
Nguyen MH; Leather H; Clancy CJ; Cline C; Jantz MA; Kulkarni V; Wheat LJ; Wingard JR
Biol Blood Marrow Transplant; 2011 Jul; 17(7):1043-50. PubMed ID: 21087680
[TBL] [Abstract][Full Text] [Related]
6. Clinical utility and prognostic value of bronchoalveolar lavage galactomannan in patients with hematologic malignancies.
Luong ML; Filion C; Labbé AC; Roy J; Pépin J; Cadrin-Tourigny J; Carignan S; Sheppard DC; Laverdière M
Diagn Microbiol Infect Dis; 2010 Oct; 68(2):132-9. PubMed ID: 20846585
[TBL] [Abstract][Full Text] [Related]
7. Impact of bronchoalveolar lavage galactomannan on the outcome of patients at risk for invasive pulmonary aspergillosis.
Danpornprasert P; Foongladda S; Tscheikuna J
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S86-93. PubMed ID: 20364562
[TBL] [Abstract][Full Text] [Related]
8. Utility of galactomannan antigen detection in bronchoalveolar lavage fluid in immunocompromised patients.
Brownback KR; Pitts LR; Simpson SQ
Mycoses; 2013 Sep; 56(5):552-8. PubMed ID: 23496321
[TBL] [Abstract][Full Text] [Related]
9. Aspergillus-Specific Lateral-Flow Device and Real-Time PCR Testing of Bronchoalveolar Lavage Fluid: a Combination Biomarker Approach for Clinical Diagnosis of Invasive Pulmonary Aspergillosis.
Johnson GL; Sarker SJ; Nannini F; Ferrini A; Taylor E; Lass-Flörl C; Mutschlechner W; Bustin SA; Agrawal SG
J Clin Microbiol; 2015 Jul; 53(7):2103-8. PubMed ID: 25903568
[TBL] [Abstract][Full Text] [Related]
10. Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid.
Musher B; Fredricks D; Leisenring W; Balajee SA; Smith C; Marr KA
J Clin Microbiol; 2004 Dec; 42(12):5517-22. PubMed ID: 15583275
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of invasive pulmonary aspergillosis in children with bronchoalveolar lavage galactomannan.
de Mol M; de Jongste JC; van Westreenen M; Merkus PJ; de Vries AH; Hop WC; Warris A; Janssens HM
Pediatr Pulmonol; 2013 Aug; 48(8):789-96. PubMed ID: 22949309
[TBL] [Abstract][Full Text] [Related]
12. Galactomannan detection in bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in patients with hematological diseases-the role of factors affecting assay performance.
Racil Z; Kocmanova I; Toskova M; Buresova L; Weinbergerova B; Lengerova M; Rolencova M; Winterova J; Hrncirova K; Volfova P; Skrickova J; Mayer J
Int J Infect Dis; 2011 Dec; 15(12):e874-81. PubMed ID: 22040924
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of glucan and galactomannan tests with real-time PCR for diagnosis of invasive aspergillosis in a neutropenic rat model].
Aydoğan S; Kuştimur S; Kalkancı A
Mikrobiyol Bul; 2010 Jul; 44(3):441-52. PubMed ID: 21063994
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic role of polymerase chain reaction in bronchoalveolar lavage fluid for invasive pulmonary aspergillosis in immunocompromised patients - A retrospective cohort study.
Hardak E; Fuchs E; Leskes H; Geffen Y; Zuckerman T; Oren I
Int J Infect Dis; 2019 Jun; 83():20-25. PubMed ID: 30926540
[TBL] [Abstract][Full Text] [Related]
15. Performance of lateral flow device and galactomannan for the detection of Aspergillus species in bronchoalveolar fluid of patients at risk for invasive pulmonary aspergillosis.
Miceli MH; Goggins MI; Chander P; Sekaran AK; Kizy AE; Samuel L; Jiang H; Thornton CR; Ramesh M; Alangaden G
Mycoses; 2015 Jun; 58(6):368-74. PubMed ID: 25996144
[TBL] [Abstract][Full Text] [Related]
16. Testing the performance of a prototype lateral flow device using bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in high-risk patients.
Castillo CG; Kauffman CA; Zhai J; Jiang H; Agozino SM; Miceli MH
Mycoses; 2018 Jan; 61(1):4-10. PubMed ID: 28905439
[TBL] [Abstract][Full Text] [Related]
17. Comparison of antigen detection and PCR assay using bronchoalveolar lavage fluid for diagnosing invasive pulmonary aspergillosis in patients receiving treatment for hematological malignancies.
Verweij PE; Latgé JP; Rijs AJ; Melchers WJ; De Pauw BE; Hoogkamp-Korstanje JA; Meis JF
J Clin Microbiol; 1995 Dec; 33(12):3150-3. PubMed ID: 8586691
[TBL] [Abstract][Full Text] [Related]
18. Bronchoalveolar galactomannan in invasive pulmonary aspergillosis: a prospective study in pediatric patients.
Mohammadi S; Khalilzadeh S; Goudarzipour K; Hassanzad M; Mahdaviani A; Aarabi N; Pourabdollah M; Sigari N
Med Mycol; 2015 Sep; 53(7):709-16. PubMed ID: 26229150
[TBL] [Abstract][Full Text] [Related]
19. Detection of invasive pulmonary aspergillosis in haematological malignancy patients by using lateral-flow technology.
Thornton C; Johnson G; Agrawal S
J Vis Exp; 2012 Mar; (61):. PubMed ID: 22473419
[TBL] [Abstract][Full Text] [Related]
20. Direct comparison of galactomannan performance in concurrent serum and bronchoalveolar lavage samples in immunocompromised patients at risk for invasive pulmonary aspergillosis.
Boch T; Buchheidt D; Spiess B; Miethke T; Hofmann WK; Reinwald M
Mycoses; 2016 Feb; 59(2):80-5. PubMed ID: 26627577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
